Spartan Gold: Goldfish Point and more

pg 86

a HydroWorx endless-lap pool
http://hydroworx.com/?gclid=CIW32N6t064CFcldTAodR00Kaw

HydroWorx makes a variety of underwater treadmills - I was unable to find an "endless lap" pool, however. Presumbably . it's a box full of water, deep enough so that someone can make a swimming motion while not going anywhere.

three Mac Pro workstations

The Mac Pro is a workstation computer manufactured by Apple Inc. The machines are based on Xeon microprocessors, but are similar to the Power Mac G5 they replaced in terms of outward appearance and expansion capabilities. The Mac Pro, in most configurations, is the fastest computer that Apple offers and one of three desktop computers in the current Macintosh lineup, the other two being the iMac and Mac Mini.

The first Mac Pro was based on dual Dual-core Xeon Woodcrest processors and formally announced on August 7, 2006 at WWDC. A new Intel Xeon-based Xserve was announced along with the Mac Pro, completing Apple's transition from the PowerPC to x86 architecture.

On April 4, 2007, a dual Quad-core Xeon Clovertown model was launched and it was replaced on January 8, 2008 by a dual Quad-core Xeon Harpertown model. The current model Mac Pro was announced on July 27, 2010 and features Intel Xeon processors based on the Nehalem microarchitecture/Westmere microarchitecture. There are options of up to 12 processing cores, up to four optional 2TB hard disk drives/512GB solid state drives and ATI Radeon HD 5770/5870 graphics.

On November 5, 2010, Apple introduced the Mac Pro Server, which—alongside the server option for the Mac mini—replace the Xserve line of Apple servers as of January 2011.

pg 92

"Please tell me you haven't found a bottle full of liquid Ebola."

Ebola virus disease (EVD) (or more commonly, Ebola hemorrhagic fever (EHF)) is the name for the human disease which may be caused by any of the five known ebolaviruses. These five viruses are: Bundibugyo Ebolavirus (BEBOV or BDBV), Zaire Ebolavirus (ZEBOV or ambiguously, EBOV), Sudan Ebolavirus (SEBOV or SUDV), Reston Ebolavirus (REBOV) and Taï Forest virus (TAFV, formerly and more commonly Cote d'Ivoire Ebolavirus (Ivory Coast Ebolavirus, CIEBOV)). EVD is a viral hemorrhagic fever (VHF), and is clinically nearly indistinguishable from Marburg virus disease (MVD).

EVD/EHF is clinically indistinguishable from Marburg virus disease (MVD), and it can also easily be confused with many other diseases prevalent in Equatorial Africa, such as other viral hemorrhagic fevers, falciparum malaria, typhoid fever, shigellosis, rickettsial diseases, cholera, gram-negative septicemia or EHEC enteritis. The most detailed studies on the frequency, onset, and duration of EVD clinical signs and symptoms were performed during the 1995 outbreak in Kikwit, Zaire (EBOV)[13][14][15] and the 2007-2008 outbreak in Bundibugyo, Uganda (BDBV).

The mean incubation period, best calculated currently for EVD outbreaks due to EBOV infection, is 12.7 days (standard deviation = 4.3 days), but can be as long as 25 days. EVD begins with a sudden onset of an influenza-like stage characterized by general malaise, fever with chills, arthralgia and myalgia, and chest pain. Nausea is accompanied by abdominal pain, anorexia, diarrhea, and vomiting. Respiratory tract involvement is characterized by pharyngitis with sore throat, cough, dyspnea, and hiccups.

The central nervous system is affected as judged by the development of severe headaches, agitation, confusion, fatigue, depression, seizures, and sometimes coma. The circulatory system is also frequently involved, with the most prominent signs being edema and conjunctivitis. Hemorrhagic symptoms are infrequent (fewer than 10% of cases for most serotypes), (the reason why Ebola hemorrhagic fever (EHF) is a misnomer) and include hematemesis, hemoptysis, melena, and bleeding from mucous membranes (gastroinestinal tract, nose, vagina and gingiva).

Cutaneous presentation may include: maculopapular rash, petechiae, purpura, ecchymoses, and hematomas (especially around needle injection sites). Development of hemorrhagic symptoms is generally indicative of a negative prognosis.

However, contrary to popular belief, hemorrhage does not lead to hypovolemia and is not the cause of death (total blood loss is low except during labor). Instead, death occurs due to multiple organ dysfunction syndrome (MODS) due to fluid redistribution, hypotension, disseminated intravascular coagulation, and focal tissue necroses.